News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
NIH IRP Senior Investigator and Inventor Heinz Feldmann, M.D., was elected to the National Academy of Medicine (NAM). Dr. Feldmann is the chief of the Laboratory of Virology at the National Institute of Allergy and Infectious Diseases (NIAID). He led the development of the technology that resulted
Join Michael Salgaller, NCI Invention Development and Marketing Unit, and Steven Ferguson, OTT Special Advisor, for a presentation on Technology Development and Commercialization: Impacting Pipelines and Bottom Lines. They will be speaking at the Therapeutics Area Partnerships (TAP) Oncology
Join Steven Ferguson, Deputy Director of Licensing & Entrepreneurship, NIH Office of Technology Transfer, as he speaks at the Innovation Under Pressure series on a variety of technology transfer topics. He is sharing his perspective on technology transfer, licensing and entrepreneurship, and advice